References
[1] Burstein, H.J. and Monica, M. (2008) Malignant Tumors of the Breast. In: Devita, V.T., Lawrence, T.S. and Rosenberg, S.A., Eds., Cancer Principles & Practice of Oncology, Vol. 2, Williams and Wilkins, Wolters Kluwer Lippincott, 1606-1654.
[2] Shahla, M. (2000) Assessment of Prognostic Factors in Breast Fine-Needle Aspirates. American Journal of Clinical Pathology, 113, S84-S96.
[3] Andrew, G. and Charles, S. (2000) Integrin-Mediated Survival Signals Regulate the Apoptotic Functions of Bax through Its Conformation and Subcellular Localization. The Journal of Cell Biology, 149, 431-445.
http://dx.doi.org/10.1083/jcb.149.2.431
[4] Lipponen, P. and Aaltomaa, S. (1994) Apoptosis in Bladder Cancer as Related To Standard Prognostic Factors and Prognosis. The Journal of Pathology, 173, 333-339.
http://dx.doi.org/10.1002/path.1711730408
[5] Stennicke, H.R. and Salvesen, G.S. (1998) Properties of the Caspases. Biochimica et Biophysica Acta, 1387, 17-31.
http://dx.doi.org/10.1016/S0167-4838(98)00133-2
[6] Thornberry, N.A. and Lazebnik, Y. (1998) Caspases: Enemies within. Science (Wash. DC), 281, 1312-1316.
http://dx.doi.org/10.1126/science.281.5381.1312
[7] Keane, M.M., Ettenberg, S.A., Nau, M.M., et al. (1999) Chemotherapy Augments TRAIL-Induced Apoptosis in Breast Cell Lines. Cancer Research, 59, 734-741.
[8] Bellarosa, D., Ciucci, A., Bullo, A., Nardelli, F., et al. (2001) Apoptotic Events in a Human Ovarian Cancer Cell Line Exposed to Anthracyclines. Journal of Pharmacology and Experimental Therapeutics, 296, 276-283.
[9] Kottke, T.J., Blajeski, A.L., Martins, M.L., Mesner, P.W., et al. (1999) Comparison of Paclitaxel-, 5-fluoro-2-Deoxyuridine-, and Epidermal Growth Factor (EGF)-Induced Apoptosis. The Journal of Biological Chemistry, 274, 15927-15936.
http://dx.doi.org/10.1074/jbc.274.22.15927
[10] Suzuki, A., Kawabata, T. and Kato, M. (1998) Necessity of Interleukin-1β Converting Enzyme Cascade in Taxotere-Initiated Death Signaling. European Journal of Pharmacology, 343, 87-92.
http://dx.doi.org/10.1016/S0014-2999(97)01520-3
[11] Linder, S. (2007) Cytokeratin Markers Come of Age. Tumor Biology, 28, 189-195.
http://dx.doi.org/10.1159/000107582
[12] Ueno, T., Toi, M. and Linder, S. (2005) Detection of Epithelial Cell Death in the Body by Cytokeratin 18 Measurement. Biomed Pharmacother, 59, S359-S362.
http://dx.doi.org/10.1016/S0753-3322(05)80078-2
[13] Leers, M.P., Kolgen, W., Bjorklund, V., Bergman, T., et al. (1999) Immunocytochemical Detection and Mapping of a Cytokeratin 18 Neoepitope Exposed during Early Apoptosis. The Journal of Pathology, 187, 567-572.
[14] de Haas, E.C., di Pietro, A., Simpson, K.L., Meijer, C., et al. (2008) Clinical Evaluation of M30 and M65 ELISA Cell Death Assays as Circulating Biomarkers in a Drug-Sensitive Tumor, Testicular Cancer. Neoplasia, 10, 1041-1048.
[15] Wu, Y.X., Wang, J.H., Wang, H. and Yang, X.Y. (2003) Study on Expression of Ki-67, Early Apoptotic Protein M30 in Endometrial Carcinoma and Their Correlation with Prognosis. Zhonghua Bing Li Xue Za Zhi, 32, 314-318.
[16] Yaman, E., Coskun, U., Sancak, B., Buyukberber, S., Ozturk, B. and Benekli, M. (2010) Serum M30 Levels Are Associated with Survival in Advanced Gastric Carcinoma Patients. International Immunopharmacology, 10, 719-722.
http://dx.doi.org/10.1016/j.intimp.2010.03.013
[17] Scholl, S.M., Beuzeboc, P., Harris, A.L., Pierga, J.Y., Asselain, B., Palangié, T., et al. (1998) Is Primary Chemotherapy Useful for All Patients with Primary Invasive Breast Cancer? Recent Results in Cancer Research, 152, 217-226.
http://dx.doi.org/10.1007/978-3-642-45769-2_21
[18] Holdenrieder, S. and Stieber, P. (2004) Apoptotic Markers in Cancer. Clinical Biochemistry, 37, 605-617.
http://dx.doi.org/10.1016/j.clinbiochem.2004.05.003
[19] Degterev, A. and Yuan, J. (2008) Expansion and Evolution of Cell Death Programmes. Nature Reviews Molecular Cell Biology, 9, 378-390.
http://dx.doi.org/10.1038/nrm2393
[20] Olofsson, M.H., Ueno, T., Pan, Y., Xu, R., Cai, F., van der Kuip, H., et al. (2007) Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy. Clinical Cancer Research, 13, 3198-3206.
http://dx.doi.org/10.1158/1078-0432.CCR-07-0009
[21] Meyn, R.E., Stephens, L.C., Hunter, N.R. and Milas, L. (1995) Apoptosis in Murine Tumors Treated with Chemotherapy Agents. Anti-Cancer Drugs, 6, 443-450.
http://dx.doi.org/10.1097/00001813-199506000-00013
[22] Ellis, P.A., Smith, I.E., McCarthy, K., Detre, S., Salter, J. and Dowsett, M. (1997) Preoperative Chemotherapy Induces Apoptosis in Early Breast Cancer. The Lancet, 349, 849.
http://dx.doi.org/10.1016/S0140-6736(05)61752-7
[23] Green, A.M. and Steinmetz, N.D. (2002) Monitoring Apoptosis in Real Time. Cancer Journal, 8, 82-92.
http://dx.doi.org/10.1097/00130404-200203000-00002
[24] Morse, D.L., Gray, H., Payne, C.M. and Gillies, R.J. (2005) Docetaxel Induces Cell Death through Mitotic Catastrophe in Human Breast Cancer Cells. Molecular Cancer Therapeutics, 4, 1495-1504.
http://dx.doi.org/10.1158/1535-7163.MCT-05-0130
[25] Jordan, M.A., Wendell, K., Gardiner, S., Derry, W.B., Copp, H. and Wilson, L. (1996) Mitotic Block Induced in HeLa Cells by Low Concentrations of Paclitaxel (Taxol) Results in Abnormal Mitotic Exit and Apoptotic Cell Death. Cancer Research, 56, 816-825.
[26] Blajeski, A.L., Kottke, T.J. and Kaufmann, S.H. (2001) A Multistep Model for Paclitaxel-Induced Apoptosis in Human Breast Cancer Cell Lines. Experimental Cell Research, 270, 277-288.
http://dx.doi.org/10.1158/1535-7163.MCT-05-0130